Ceribell: AI EEGs Become Standard in [Acute Care Hospitals] – Market Potential Grows to $2.4 Billion!

The Silicon Valley company Ceribell (CBLL) can address an underserved market for the detection of status epilepticus with AI-powered EEGs that can be used directly at the bedside. Every intensive care unit and emergency department should benefit from the Ceribell system. Ceribell aids with a headband, cloud portal, and the Clarify algorithm, particularly in the detection of non-convulsive seizures (NCSE), which account for 92% of cases in intensive care units and are often only visible on the EEG without obvious convulsions. A significant gap in...